Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

COVID-19 may trigger hair loss conditions like alopecia areata.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

New treatments are needed for non-scarring alopecia due to current limitations.

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.

Four natural compounds were found to promote hair growth effectively.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Dupilumab may help treat alopecia areata, but more research is needed.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.